SECURITIES AND EXCHANGE COMMISSION
                         Washington, DC 20549

                             Form 10-QSB
       QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE
                   SECURITIES EXCHANGE ACT OF 1934

           For the quarterly period ended NOVEMBER 30, 2006
                        File Number 000-51421

                       CORE MEDICAL GROUP, INC.
                   (f/k/a Swap and Shop.net Corp.)
    -------------------------------------------------------------
  (Exact name of small business issuer as specified in its charter)


                  Florida                        20-1449332
          --------------------------          ----------------
        State or other Jurisdiction of       (I.R.S. Employer
        incorporation or organization)       Identification No.)


                     1016 CLEMONS STREET, SUITE 302
                   PALM BEACH GARDENS, FLORIDA 33410
                 ------------------------------------
               (Address of principal executive offices)


                            (561) 880-0004
           ------------------------------------------------
         (Registrant's telephone number, including area code)

Check whether the issuer (1) filed all reports required to be filed
by Section 13 or 15 (d) of the Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.        Yes [   ]  No [ X ]

As of NOVEMBER 30, 2006 the issuer had 19,186,340 shares of common
stock, $.01 Par Value, outstanding.

Transitional Small Business Disclosure format:   Yes [   ]  No [ X ]

On March 3, 2005 SWAP AND SHOP.NET CORP. applied and received Cusip
Number:  869894 10 5

On March 23, 2005 SWAP AND SHOP.NET CORP. received CIK Number: 1321510

On August 2, 2006 SWAP AND SHOP.NET CORP. changed its name with the Florida
Secretary of State to CORE MEDICAL GROUP, INC.

On Feb. 16, 2007 CORE MEDICAL GROUP, INC. received CUSIP Number 218684 10 8.





CORE MEDICAL GROUP, INC.           FORM 10-QSB             NOVEMBER 30, 2006
(f/k/a Swap and Shop.net Corp.)
A Development Stage Company
                                      INDEX
                                                                     PAGE NO.

PART I       FINANCIAL INFORMATION

ITEM 1  FINANCIAL STATEMENTS

        Report Of Independent Registered Public Accounting Firm . . . . .3

        Balance Sheets
         November 30, 2006 and May 31, 2006 . . . . . . . . . . . . . . .4

        Statements of Operations
         Six Months Ended November 30, 2006 and 2005
          and from Inception, March 1, 2004 through November 30, 2006 . .5

        Three Months Ended November 30, 2006 and 2005 . . . . . . . . . .6

        Statement of Changes in Stockholders' Equity
         from Inception, March 1, 2004, through November 30, 2006 . . . .7

        Statements of Cash Flows
         Six Months Ended November 30, 2006 and 2005 and
          from Inception, March 1, 2004, through November 30, 2006. . . .8

        Notes to Financial Statements. . . . . . . . . . . . . . . . . .10

ITEM 2  Management's Discussion and Analysis or Plan of Operation. . . .16

ITEM 3  Controls and Procedures. . . . . . . . . . . . . . . . . . . . .21

PART II       OTHER INFORMATION

ITEM 1  Legal Proceedings. . . . . . . . . . . . . . . . . . . . . . . .22

ITEM 2  Unregistered Sales of Equity Securities and Use of Proceeds. . .22

ITEM 3  Defaults Upon Senior Securities. . . . . . . . . . . . . . . . .22

ITEM 4  Submission of Matters to a Vote Of Security Holders. . . . . . .22

ITEM 5  Subsequent Events. . . . . . . . . . . . . . . . . . . . . . . .22

ITEM 6  Exhibits . . . . . . . . . . . . . . . . . . . . . . . . . . . .22

SIGNATURES AND CERTIFICATIONS. . . . . . . . . . . . . . . . . . . . . .23

                                      2








                  Wieseneck, Andres & Company, P.A.
                   Certified Public Accountants
                   772 U.S. Highway 1, Suite 100
                  North Palm Beach, Florida 33408
                          (561) 626-0400


Thomas B. Andres, C.P.A.*, C.V.A.                 FAX (561) 626-3453
Paul M. Wieseneck, C.P.A.
*Regulated by the State of Florida


             REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


To the Board of Directors and Stockholders
Core Medical Group, Inc.
(f/k/a Swap and Shop.net Corp.)
A Development Stage Enterprise
Jupiter, Florida

We have reviewed the accompanying balance sheets of Core Medical Group, Inc., a
Development Stage Enterprise, as of November 30, 2006 and May 31, 2006, and the
related statements of operations for six month periods ended November 30, 2006
and 2005 and from Inception, March 1, 2004, through November 30, 2006, the
related statements of operations for three month periods ended November 30,
2006 and 2005, the statement of changes in stockholders' equity from March 1,
2004 through November 30, 2006 and the statement of cash flows for the six
month periods ended November 30, 2006 and 2005 and Inception, March 1, 2004
through November 30, 2006. These financial statements are the responsibility of
the company's management.

We conducted our review in accordance with the standards established by the
Public Company Accounting Oversight Board (United States).  A review of interim
financial information consists principally of applying analytical procedures
and making inquiries of persons responsible for financial and accounting
matters. It is substantially less in scope than an audit conducted in
accordance with standards of the Public Company Accounting Oversight Board
(United States), the objective of which is the expression of an opinion
regarding the financial statements taken as a whole. Accordingly, we do not
express such an opinion.

Based on our review, we are not aware of any material modifications that should
be made to the accompanying interim financial statements for them to be in
conformity with U.S. generally accepted accounting principles.



/s/Wieseneck, Andres & Company, P.A.


North Palm Beach, Florida
March 23, 2007

                                      3


CORE MEDICAL GROUP, INC.
(f/k/a Swap and Shop.net Corp.)
A Development Stage Company
BALANCE SHEETS
(UNAUDITED)
                                   NOVEMBER 30, 2006       MAY 31, 2006
                                     -------------         ------------
ASSETS
  Current Assets
    Cash and Cash Equivalents         $       480           $        49
    Prepaid Expense                             9                 5,009
    Loan Receivable Related Parties         3,700                 3,700
                                      -----------           -----------
Total Current Assets                        4,189                 8,758
                                      -----------           -----------
TOTAL ASSETS                          $     4,189           $     8,758
                                      ===========           ===========

LIABILITIES & STOCKHOLDERS' EQUITY
  Liabilities
    Current Liabilities
      Accounts Payable                $    13,495           $     9,904
      Loan Payable                             79                 4,350
      Shareholder Loans Payable                 -                20,930
                                      -----------           -----------
    Total Current Liabilities              13,574                35,184
                                      -----------           -----------
  Total Liabilities                        13,574                35,184
                                      -----------           -----------
  Stockholders' Equity
    Common Stock $.01 par value:
    100 million shares authorized;
    Shares issued and outstanding:
    19,186,340 at November 30, 2006
    and 11,742,479 at May 31, 2006        191,863              117,425
    Paid-in Capital                        (4,995)              (4,995)
    Deficit Accumulated during
    the Development Stage                (196,253)            (138,856)
                                      -----------          -----------
    Total Stockholders' Equity             (9,385)             (26,426)
                                      -----------          -----------
TOTAL LIABILITIES
 & STOCKHOLDERS' EQUITY               $     4,189          $     8,758
                                      ===========          ===========

Read accompanying summary of accounting policies, notes to
financial statements and independent accountants' review report.



                                       4






CORE MEDICAL GROUP, INC.
(f/k/a Swap and Shop.net Corp.)
A Development Stage Company
STATEMENTS OF OPERATIONS
FOR THE SIX MONTHS ENDED NOVEMBER 30, 2006 AND 2005
AND FROM INCEPTION, MARCH 1, 2004 THROUGH NOVEMBER 30, 2006
(UNAUDITED)
                                                           INCEPTION
                                                         MARCH 1, 2004
                                                            THROUGH
                                2006            2005   NOVEMBER 30, 2006
                            ------------   ------------   ------------
Revenues
  Net Sales                 $         -    $         -    $         -
  Cost of Sales                       -              -              -
                            ------------   ------------  ------------
    Gross Profit                      -              -              -

Operating Expenses
  General and Administrative     57,397         57,710        196,253
                            ------------   ------------  ------------
    Total Operating Expenses     57,397         57,710        196,253
                            ------------   ------------  ------------
    Loss from Operations        (57,397)       (57,710)      (196,253)
                            ------------   ------------  ------------
Net Loss                    $   (57,397)   $   (57,710)   $  (196,253)
                            ============   ============   ============

Basic and Diluted
  Net Loss per Common Share $    (.004)    $   (.008)
                            ============   ============

Weighted Average Shares
            Outstanding      15,464,410      7,466,646
                            ============   ============







Read accompanying summary of accounting policies, notes to
financial statements and independent accountants' review report.







                                      5





CORE MEDICAL GROUP, INC.
(f/k/a Swap and Shop.net Corp.)
A Development Stage Company
STATEMENTS OF OPERATIONS
FOR THE THREE MONTHS ENDED NOVEMBER 30, 2006 AND 2005
(UNAUDITED)
                                2006            2005
                            ------------   ------------
Revenues
  Net Sales                 $         -    $         -
  Cost of Sales                       -              -
                            ------------   ------------
    Gross Profit                      -              -

Operating Expenses
  General and Administrative     17,785         11,117
                            ------------   ------------
    Total Operating Expenses     17,785         11,117
                            ------------   ------------
    Loss from Operations        (17,785)       (11,117)
                            ------------   ------------
Net Loss                    $   (17,785)   $   (11,117)
                            ============   ============

Basic and Diluted
  Net Loss per Common Share $    (.001)    $   (.001)
                            ============   ============

Weighted Average Shares
            Outstanding      18,421,058      9,391,085
                            ============   ============







Read accompanying summary of accounting policies, notes to
financial statements and independent accountants' review report.





                                      6









CORE MEDICAL GROUP, INC.
(f/k/a Swap and Shop.net Corp.)
A Development Stage Company
STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
FROM INCEPTION, MARCH 1, 2004, THROUGH NOVEMBER 30, 2006
(UNAUDITED)
                        Number    At Par    Add'l                 Total
                          of       Value   Paid In Accumulated  Stockholder
                        Shares     $.01    Capital  (Deficit)     Equity
Balance,              ---------  --------  -------- ---------   -----------
   March 1, 2004              0  $      0  $      0 $      0    $         0

Issuance of Common
  Stock to eCom eCom         1          -         -        -              -

Net Loss 2004                -          -         -       (4)            (4)

Cancellation of Common
  Stock by eCom eCom        (1)         -         -        -              -

Issuance of
  Common Stock to
  eCom eCom
  Shareholders          499,503     4,995    (4,995)       -              -

Sale of Common Stock
  (See Note M)        5,000,000    50,000         -        -         50,000

Net Loss 2005                -         -          -  (35,869)       (35,869)

Convert Related Party
  Debt to Common
  Stock (See Note N)  5,242,976    52,430         -        -         52,430

Convert Professional
  Fees to Common
  Stock               1,000,000    10,000         -        -         10,000

Net Loss 2006                -         -          - (102,983)      (102,983)

Convert Related Party
  Debt to Common Stock
  (See Note N)        6,593,861    65,938         -        -         65,938

Convert Professional
  Fees to Common Stock  850,000     8,500         -        -          8,500

Net Loss Year-to-Date        -         -          -  (57,397)       (57,937)

Balance,             ----------  --------  -------- ----------  ------------
  November 30, 2006  19,186,340  $191,863  $(4,995) $(196,253)  $    (9,385)
                     ==========  ========  ======== ==========  ============

Read accompanying summary of accounting policies, notes to financial
statements and independent accountants' review report.

                                       7
CORE MEDICAL GROUP, INC.
(f/k/a Swap and Shop.net Corp.)
A Development Stage Company
STATEMENTS OF CASH FLOWS
FOR THE SIX MONTHS ENDED NOVEMBER 30, 2006 AND 2005
AND FROM INCEPTION, MARCH 1, 2004, THROUGH NOVEMBER 30, 2006
(UNAUDITED)
                                                               INCEPTION
                                                             MARCH 1, 2004
                                                                THROUGH
                                        2006        2005   NOVEMBER 30, 2006
                                     ----------  ----------   ----------
Cash Flows From Operating Activities
  Cash received from customers       $       -   $       -    $       -

  Cash paid to suppliers of goods
      and services                     (48,807)    (11,357)    (135,357)
                                     ----------  ----------   ----------
   Net Cash Flows Used in
       Operating Activities            (48,807)    (11,357)    (135,357)
                                     ----------  ----------   ----------

Cash Flows From Investing Activities         -           -            -
                                     ----------  ----------   ----------
   Net Cash Flows Used in
        Investing Activities                 -           -            -

Cash Flows From Financing Activities
  Sale of Common Stock                  74,439           -      124,439

  Proceeds of loans from shareholders  (20,930)          -       15,098

  Loans from related company            (4,271)          -            -

  Loans to related company                   -     (38,000)      (3,700)
                                     ----------  ----------   ----------
   Net Cash Flows Provided By
       (Used In) Financing Activities   49,238     (38,000)     135,837
                                     ----------  ----------   ----------
Net Increase / (Decrease) in Cash          431     (49,357)         480

Cash and Cash Equivalents at
 Beginning of Period                        49      50,677            0

                                     ----------  ----------   ----------
Cash and Cash Equivalents at
 End of Period                       $     480   $   1,320    $     480
                                     ==========  ==========   ==========

Read accompanying summary of accounting policies, notes to
financial statements and independent accountants' review report.


                                      8



CORE MEDICAL GROUP, INC.
(f/k/a Swap and Shop.net Corp.)
A Development Stage Company
STATEMENTS OF CASH FLOWS
FOR THE SIX MONTHS ENDED
NOVEMBER 30, 2006 AND 2005
(UNAUDITED)

Reconciliation of Net Loss to Net Cash Flows Used in Operating
Activities

                                                  2006             2005
                                              ------------     ------------

  Net Income (Loss)                           $   (57,397)     $   (57,710)

  Add items not requiring outlay of cash:
   Depreciation and amortization                        -                7
   Convert payable to equity                            -           42,708

Cash was increased by:
   Decrease in prepaid assets                       5,000                -
   Increase in accounts payable                     3,590            3,638

                                              ------------     ------------
      Net Cash Flows Used in
       Operating Activities                   $   (48,807)       $ (11,357)
                                              ============     ============









Read accompanying summary of accounting policies, notes to
financial statements and independent accountants' review report.
















                                       9

CORE MEDICAL GROUP, INC.
(f/k/a Swap and Shop.net Corp.)
A Development Stage Company
NOTES TO FINANCIAL STATEMENTS


NOTE A - HISTORY AND DESCRIPTION OF BUSINESS

On February 12, 1999, eCom eCom.com, Inc. acquired the rights to the completed
technology, customer lists and domain names for the Swap and Shop web site and
formed a division called Swap and Shop.net.

Pursuant to SEC Staff Legal Bulletin No. 4, eCom decided to spin off Swap and
Shop.net into an independent company in the belief that the independent
company, with a distinct business, would be better able to obtain necessary
funding and develop its business plans.

On December 2, 2003, the Board of Directors of eCom eCom.com, Inc., approved
the spin-off of Swap and Shop.net.

Swap and Shop.net Corp. (the "Company") was incorporated in the State of
Florida on March 1, 2004 as a wholly owned subsidiary of eCom eCom.com, Inc.

eCom eCom.com, Inc. spun off Swap and Shop.net Corp. on June 4, 2004. Swap and
Shop.net Corp. changed its name to Core Medical Group, Inc. on August 2, 2006
to better reflect the industry within which an operating company was sought for
merger or acquisition.

The Company's main office is located at 1016 Clemons Street, Suite 302,
Jupiter, FL 33477. The telephone number is (561) 880-0004.

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

BASIS OF PRESENTATION, USE OF ESTIMATES
The Company maintains its accounts on the accrual basis of accounting. The
preparation of financial statements in conformity with U.S. generally accepted
accounting principles requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial statements and
the reported amounts of revenues and expenses during the reporting period.
Actual results could differ from those estimates.

REVENUE RECOGNITION
Product revenue is recognized when the product is shipped. Service revenue is
recognized when the service is complete. Dividends from investments are
recognized when declared payable by the underlying investment.  Capital gains
and losses are recorded on the date of the sale of the investment.

CASH
Cash consists of deposits in banks and other financial institutions
Having original maturities of less than ninety days.


                                    10



CORE MEDICAL GROUP, INC.
(f/k/a Swap and Shop.net Corp.)
A Development Stage Company
NOTES TO FINANCIAL STATEMENTS

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

ALLOWANCE FOR DOUBTFUL ACCOUNTS
It is the policy of management to review the outstanding accounts receivable at
year end, as well as the bad debt write-offs experienced in the past, and
establish an allowance for doubtful accounts for uncollectible amounts.

DEPRECIATION
Property and equipment will be recorded at cost and depreciated over the
estimated useful lives of the related assets. Depreciation will be computed
using the straight-line method.

AMORTIZATION
The accounting for a recognized intangible asset acquired after June 30, 2001
is based on its useful life to the Company. If an intangible asset has a finite
life, but the precise length of that life is not known, that intangible asset
shall be amortized over management's best estimate of its useful life. An
intangible asset with an indefinite useful life is not amortized. The useful
life to an entity is the period over which the asset is expected to contribute
directly or indirectly to the future cash flows of that entity.

RECLASSIFICATION
Certain reclassifications have been made to the prior year financial statements
in order for them to be in conformity with the current year presentation.

NOTE C - LOANS RECEIVABLE RELATED PARTIES

The loans receivable from related companies are non-interest bearing, non-
collateralized and due on demand.

NOTE D - PREPAID EXPENSES

Prepaid expense consists of Professional Consulting fees.

NOTE E - DEVELOPMENT STAGE ENTERPRISE

The Company has been and is currently in the development stage. It is the
intention of management to merge with or acquire a company engaged in a branch
of the health care industry.

NOTE F- LOANS PAYABLE

The loans payable for 2006 and 2005 in the amounts of $79 and $4,350 are
non-interest bearing, non-collateralized and due on demand.

NOTE G - INCOME TAXES

No provision for federal and state income taxes has been recorded because the
Company has incurred net operating losses since inception. The Company's net


                                    11
CORE MEDICAL GROUP, INC.
(f/k/a Swap and Shop.net Corp.)
A Development Stage Company
NOTES TO FINANCIAL STATEMENTS

NOTE G   INCOME TAXES (CONTINUED)

operating loss carryforward as of November 30, 2006 totals approximately
$190,000.  These carry forwards, which will be available to offset future
taxable income, expire beginning in 2024.

The Company accounts for income taxes in accordance with FASB Statement No.
109, Accounting for Income Taxes (FASB 109). Under FASB 109, income taxes are
provided for the tax effects of transactions reported in the financial
statements and consist of taxes currently due plus deferred taxes related to
certain income and expenses recognized in different periods for financial and
income tax reporting purposes. Deferred tax assets and liabilities represent
the future tax return consequences of those differences, which will either be
taxable or deductible when the assets and liabilities are recovered or settled.
Deferred taxes also are recognized for operating losses and tax credits that
are available to offset future taxable income and income taxes, respectively.
A valuation allowance is provided if it is more likely than not that some or
all of the deferred tax asset will not be realized.  See Note I.

NOTE H - SHAREHOLDERS' EQUITY

The computation of diluted loss per share does not include shares from
otentially dilutive securities as the assumption of conversion or exercise of
these would have an antidilutive effect on loss per share. In accordance with
generally accepted accounting principles, diluted loss per share is calculated
using the same number of potential common shares as used in the computation of
loss per share before extraordinary items.

NOTE I - DEFERRED TAX ASSET

Deferred income taxes are provided for temporary differences between the
financial reporting and income tax basis of the Company's assets and
liabilities. Temporary differences, net operating loss carry forwards and
valuation allowances comprising the net deferred taxes on the balance sheets is
as follows:
                                                  NOVEMBER 30, 2006
                                                  -----------------
       Loss carry forward for tax purposes          $    190,000
                                                   ===============
       Deferred tax asset (34%)                           64,600
       Valuation allowance                               (64,600)
                                                   ---------------
       Net deferred tax asset                       $          0
                                                   ===============

The Company does not believe that the realization of the related net deferred
tax asset meets the criteria required by generally accepted accounting
principles and, accordingly, the deferred income tax asset arising from such
loss carry forward has been fully reserved.

                                    12

CORE MEDICAL GROUP, INC.
(f/k/a Swap and Shop.net Corp)
A Development Stage Company
NOTES TO FINANCIAL STATEMENTS

NOTE J - RELATED PARTY TRANSACTIONS

The Company has notes payables due to related company entities. eCom eCom.com,
Inc. is owed $79 for funds advanced to the Company for its operations.

The Company is allocated certain expenses such as rent, travel and office and
administrative that are paid on behalf of the Company by American Capital
Holdings, Inc., a company that is related to the Company by mutual stockholders
and directors. The total expense allocated to the Company during the six months
ended November 30, 2006 was $26,915. A portion of the liabilities payable to
American Capital are converted to common stock and paid in capital at the end
of each reporting period.

NOTE K - SUBSEQUENT EVENTS

None

NOTE L - RECENT ACCOUNTING PRONOUNCEMENTS

The FASB issued SFAS No. 150, Accounting for Certain Financial Instruments with
Characteristics of both Liabilities and Equity, and is effective for financial
instruments entered into after May 31, 2003.  This Statement establishes
standards for how an issuer classifies and measures in its statement of
financial position certain financial instruments with characteristics of both
liabilities and equity.  It requires that an issuer classify a financial
instrument that is within its scope as a liability because that financial
instrument embodies an obligation of the issuer.

Statement of Financial Accounting Standards No. 151, Inventory Costs, is an
amendment of ARB No. 43, Chapter 4 and is effective for inventory costs
incurred during fiscal years beginning after June 15, 2005.  This statement
amends ARB 43, Chapter 4, to clarify that abnormal amounts of idle facility
expense, freight, handling costs, and wasted materials (spoilage) should be
recognized as current-period charges.  In addition, this Statement requires
that allocation of fixed production overheads to the costs of conversion be
based on the normal capacity of the production facilities.  Statement of
Financial Accounting Standards No. 152, Accounting for Real Estate Time-Sharing
Transactions, is an amendment of FASB Statements No. 66 and 67.

Statement of Financial Accounting Standards No. 153, Exchanges of Nonmonetary
Assets, was issued in December 2004.  The guidance in APB No. 29, Accounting
for Nonmonetary Transactions, is based on the principle that exchanges of
nonmonetary assets should be measured based on the fair value of the assets
exchanged.  The guidance in that Opinion, however, included certain exceptions
to that principle.  This Statement amends Opinion 29 to eliminate the exception
for nonmonetary exchanges of similar productive assets and replaces it with a
general exception for exchanges of nonmonetary assets that do not have
commercial substance.  A nonmonetary exchange has commercial substance if the
future cash flows of the entity are expected to change significantly as a
result of the exchange.

                                    13
CORE MEDICAL GROUP, INC.
(f/k/a Swap and Shop.net Corp)
A Development Stage Company
NOTES TO FINANCIAL STATEMENTS

NOTE L - RECENT ACCOUNTING PRONOUNCEMENTS - (CONTINUED)

Statement of Financial Accounting Standards No. 154, Accounting Changes and
Error Corrections, was issued in May 2005.  This Statement requires
retrospective application to prior periods' financial statements of changes in
accounting principle, unless it is impracticable to determine either the
period-specific effects or the cumulative effect of the change.  When it is
impracticable to determine the period-specific effects of an accounting change
on one or more individual prior periods presented, this Statement requires that
the new accounting principle be applied to the balances of assets and
liabilities as of the beginning of the earliest period for which retrospective
application is practicable and that a corresponding adjustment be made to the
opening balance of retained earnings (or other appropriate components of equity
or net assets in the statement of financial position) for that period rather
than being reported in an income statement.  When it is impracticable to
determine the cumulative effect of applying a change in accounting principle to
all prior periods, this Statement requires that the new accounting principle be
applied as if it were adopted prospectively from the earliest date practicable.
This Statement requires that retrospective application of a change in
accounting principle be limited to the direct effects of the change.  Indirect
effects of a change in accounting principle, such as a change in
nondiscretionary profit-sharing payments resulting from an accounting change,
should be recognized in the period of the accounting change.  This Statement
also requires that a change in depreciation, amortization, or depletion method
for long-lived, nonfinancial assets be accounted for as a change in accounting
estimate by a change in accounting principle.  This Statement carries forward
without change the guidance contained in Opinion 20 for reporting the
correction of an error in previously issued financial statements and a change
in accounting estimate.  This Statement also carries forward the guidance in
Opinion 20 requiring justification of a change in accounting principle on the
basis of preference.

Statement of Financial Accounting Standards No. 155, Accounting for Certain
Hybrid Financial Instruments, was issued in February 2006.  This Statement
permits fair value remeasurement for any hybrid financial instrument that
contains an embedded derivative that otherwise would require bifurcation;
clarifies which interest-only strips and principle-only strips are not subject
to the requirements of Statement 133; establishes a requirement to evaluate
interests in securitized financial assets to identify interests that are
freestanding derivatives or that are hybrid financial instruments that contain
an embedded derivative requiring bifurcation; clarifies that concentrations of
credit risk in the form of subordination are not embedded derivatives, and
amends Statement 140 to eliminate the prohibition on a qualifying
special-purpose entity from holding a derivative financial instrument that
pertains to a beneficial interest other than another derivative financial
instrument.

Statement of Financial Accounting Standards No. 156, Accounting for Servicing
of Financial Assets, was issued in March 2006.  This Statement requires an
entity to recognize a servicing asset, a contract to service financial assets
                                    14

CORE MEDICAL GROUP, INC.
(f/k/a Swap and Shop.net Corp)
A Development Stage Company
NOTES TO FINANCIAL STATEMENTS

NOTE L - RECENT ACCOUNTING PRONOUNCEMENTS - (CONTINUED)

under which the estimated future revenues from contractually specified
servicing fees, late charges, and other ancillary revenues are expected to more
than adequately compensate the servicer for performing the servicing, or
servicing liability, a contract to service financial assets under which the
estimated future revenues from contractually specified servicing fees, late
charges, and other ancillary revenues are not expected to adequately compensate
the servicer for performing the servicing, each time it undertakes an
obligation to service a financial asset by entering into a servicing contract.

SFAS No's. 150, 151, 152, 153, 154, 155 and 156 were adopted by the company and
did not have a material effect on the Company's financial position or results
of operations.

NOTE M - COMMON STOCK

American Capital Holdings, Inc., a related company in that it was also a
company spun off from eCom eCom.com, Inc., acquired 5 million shares of Core
Medical Group, Inc. common stock on May 31, 2005 for $50,000. See Note A.
American Capital Holdings, Inc. then distributed the 5 million common shares to
its shareholders in the form of a dividend. 5,242,976 common shares of Core
Medical Group, Inc. distributed to American Capital Holdings, Inc. as partial
payment of its accounts payable were also distributed to the stockholders,
prorata, of American Capital Holdings on August 7, 2006.  See note N. By
definition, Core Medical Group, Inc. is not a wholly owned subsidiary of
American Capital Holdings, Inc. in that American Capital Holdings does not
directly or indirectly own over fifty (50) percent of the outstanding voting
shares of Core Medical Group, Inc.

NOTE N - SHAREHOLDER LOAN, RELATED COMPANY ACCOUNTS PAYABLE

The Company had a portion of its prior and current year accounts payable
including rent, administrative costs, tax preparation, SEC filing costs, etc.
paid by a related company for the benefit of Core Medical Group, Inc. The
related company, American Capital Holdings, Inc., invoiced Core Medical Group,
Inc. for the expenses it paid throughout the year on its behalf. In the year
ended May 31, 2006, Core Medical Group, Inc. reduced a portion of its
outstanding accounts payable to the related company by $52,430 by issuing the
company 5,242,976 shares of its common voting shares. During the six month
period ended November 30, 2006, an additional 4,784,501 shares were issued to
American Capital Holdings to reduce additional amounts loaned to the Company.
See Note M related to the distribution of these shares.  The Company has an
outstanding balance due to American Capital Holdings, Inc. of $0 at November
30, 2006.






                                     15
CORE MEDICAL GROUP, INC.
(f/k/a Swap and Shop.net Corp)
A Development Stage Company
NOTES TO FINANCIAL STATEMENTS

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

The following discussion should be read in conjunction with the accompanying
financial statements for the six month periods ended November 30, 2006 and 2005
and the Form 10-KSB for the fiscal year ended May 31, 2006.

Special Note Regarding Forward-Looking Statements

Certain statements in this report and elsewhere (such as in other filings by
the Company with the Securities and Exchange Commission ("SEC"), press
releases, presentations by the Company of its management and oral statements)
may constitute "forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995.  Words such as "expects,"
"anticipates," "intends," "plans," "believes," "seeks," "estimates," and
"should," and variations of these words and similar expressions, are intended
to identify these forward-looking statements. The company's actual results
could differ materially from those anticipated in these forward-looking
statements.  Factors that might cause or contribute to such differences
include, among others, failure to complete a merger or acquisition with a
privately owned operating business that is generating substantial revenues,
success of the Company's business operations, failure to obtain sufficient
capital to fund those operations, and failure to meet the qualifications for
listing of the Company's stock on a major stock exchange.  The Company
undertakes no obligation to publicly release the result of any revisions to
these forward-looking statements, which may be made to reflect events or
circumstances after the date hereof or to reflect the occurrence of
unanticipated events.

History of Spin-Off Company:

On November 29, 2004 an involuntary petition was filed against eCom under
Chapter 11, Title 11 of the United States Bankruptcy Code in the United States
Southern District of Florida Bankruptcy Court in re: Case No. 04-35435-BKC-SHF.
On May 16, 2005 an Order was entered by the Honorable Judge Steven H. Friedman
whereby eCom entered into Chapter 11 proceedings.  During this May 16, 2005
hearing, Judge Friedman ordered eCom ("the Debtor"), to retain outside legal
counsel to represent the Company in the aforementioned bankruptcy proceedings.
Judge Friedman also ordered the Debtor to file the appropriate bankruptcy
schedules by no later than June 5, 2005.

On June 2, 2005, based on (a) the February 28, 2005 legal opinion eCom obtained
from James C. Volpi, Esq.; (b) the prior SEC 8K filings (put in accession
acceptance numbers) by eCom concerning the spinoff of certain former subsidiary
companies of eCom; (c) the prior press releases issued by the former CEO of
eCom; (d) the May 16, 2005 Court Order entered by the Honorable Judge Steven H.
Friedman adjudicating eCom into Chapter 11 Bankruptcy proceedings, the acting
CEO of eCom, Richard C. Turner, caused the issuance of the spinoff shares (via
the administrative efforts of petitioning creditor American Capital Holdings,
Inc.) procured the necessary SEC CIK numbers as well as Standard & Poors Cusip
numbers and issued the common shares of the following below listed companies
with a shareholder record date of May 31, 2005.
                                      16
CORE MEDICAL GROUP, INC.
(F/K/A SWAP AND SHOP.NET CORP.)
A DEVELOPMENT STAGE ENTERPRISE

No.    Name of Subsidiary Company        S&P Cusip No.          SEC CIK No.
                                        --------------       ----------------
   1   American Environmental, Inc. (1)   628703 10 0          0001290785
   2   Green Energy Group, Inc.     (2)   74270Q 10 0          0001321500
   3   Diamond Energy Partners, LP  (3)   000303 10 7          0001321506
   4   Click to Raffle.com          (4)   00089Y 10 9          0001321499
   5   Core Medical Group, Inc.     (5)   869894 10 5          0001321510
   6   CRT Holdings, Inc.           (6)   90341K 10 4          0001321508
   7   A Super Deal.com, Inc.             00210R 10 6          0001321507
   8   eSecureSoft Company                296423 10 6          0001321511

(1)   Name change filed with Florida Div. of Corporations on 11/02/05, formerly
      known as MyZipSoft, Inc.
(2)   Name change filed with Florida Div. of Corporations on 08/02/06, formerly
      known as ProCard Corporation.
(3)   Name change filed with Florida Div. of Corporations on 08/19/05, formerly
      known as AAB National Company.
(4)   Name change filed with Florida Div. of Corporations on 11/30/05, formerly
      known as A Classified Ad, Inc.
(5)   Name change filed with Florida Div. of Corporations on 08/03/06, formerly
      known as Swap and Shop.net Corp.
(6)   Name change filed with Florida Div. of Corporations on 11/30/05, formerly
      known as USAS Digital Inc.

The legal basis for issuing these shares was Section 1107 of the Bankruptcy
Code whereby this section of the code places the debtor-in-possession in the
position of a fiduciary, with the rights and powers of a chapter 11 trustee,
and requires the performance of all but the investigative functions and
duties of a trustee. These duties are set forth in the Bankruptcy Code and
Federal Rules of Bankruptcy Procedure. 11 U.S.C. Section 1106, Section 1107.
Such powers and duties include protecting the assets of the estate,
accounting for property, examining, objecting and/or eliminating potential
claims (which potential claims were the case with the spin-off equity
security holders who had not received their shares as promised), and filing
informational reports as required by the court and the United States trustee,
such as monthly operating reports. The debtor-in-possession also has many of
the other powers and duties of a trustee including the right, with the court's
approval, to employ attorneys, accountants, appraisers, auctioneers, or other
professional persons to assist the debtor during its bankruptcy case. Other
responsibilities include filing tax returns and filing such reports as are
necessary or as the court orders after confirmation, such as a final
accounting. The United States trustee is responsible for monitoring the
compliance of the debtor in possession with the reporting requirements.

On June 2, 2005, as ordered by Judge Friedman on May 16, 2005, eCom filed its
Chapter 11 Bankruptcy schedules with the United States Southern District of
Florida Bankruptcy Court.  A June 5, 2005 hearing was held in front of Judge
Steven H. Friedman regarding the pending motions for: (a) the approval of
eCom's bankruptcy legal counsel, Kluger, Peretz, Kaplan & Berlin, P.A.; (b)
the approval of Barney A. Richmond to become Chief Executive Officer of eCom;
and (c) the preliminary approval of One Hundred Thousand ($100,000) of Debtor-
In-Possession financing for eCom to be provided by petitioning creditor,
                                      17
CORE MEDICAL GROUP, INC.
(F/K/A SWAP AND SHOP.NET CORP.)
A DEVELOPMENT STAGE ENTERPRISE

American Capital Holdings, Inc.   On June 6, 2005, court orders were issued by
Judge Friedman approving the employment of Kluger, Peretz, Kaplan & Berlin, P.L
as eCom's bankruptcy legal  counsel and the approval of Barney A. Richmond as
CEO of eCom.  Copies of these June 6, 2005 court orders are attached herein as
Exhibit 99.1.  A copy of the June 5, 2005 Court transcript is obtainable on
eCom's website under www.ecomecom.net under the section titled "Bankruptcy
News".  On June 14, 2005, an Interim Order was entered on the Post Petition
$100,000 eCom Debtor-In-Possession financing provided by American Capital
Holdings, Inc., with the final hearing approval date being set for July 25,
2005.  A copy of this June 14, 2005 Order is appended as Exhibit No. 99.2.

On July 8, 2005, eCom filed an 8K information statement with the United States
Securities & Exchange Commission ("SEC") listing the SEC CIK and Standard &
Poors' Cusip numbers on the former above referenced subsidiary spin-off
companies.  On July 12, 2005 each of these spin-offs filed Form 10SBG12's with
the SEC.

On July 18, 2005  all of these above referenced companies received a letter
from the Securities and Exchange Commission asking each company to provide
legal analysis for the "spin-off" share issuance. A copy of this letter is
enclosed herein as Exhibit No. 99.3

On July 20, 2005, Debtor eCom filed a Motion To Limit Notice in the Southern
District of Florida  Bankruptcy Court for permission to perfect notice to
all interested parties via the Company's website.  On July 25, 2005 a Court
Order was entered by Judge Friedman granting this Motion To Limit Notice and
the use of electronic service to notice shareholders.  A copy of this Motion
and Order is affixed herein as Exhibit No. 99.4.

On August 4, 2005 Judge Friedman issued: (a) an Order For Relief and Notice
of Section 341 Meeting of Creditors; (b) an Order Granting
Debtor-in-Possession's Motion For Authorization to: (II) Provide Electronic
Service Upon Equity Security Holders and (II) Utilize Executive Mail Service
for Purposes of Coordinating and Effectuating Service Upon Equity Security
Holders; and (c) the Final Order Authorizing Debtor-in-Possession Financing.

In an effort to give the SEC an answer regarding their request for detailed
clarification as to the legal analysis of the spin-off companies and to comply
with the request to withdraw each of the above referenced spin-off companies'
Form 10SBG12, on August 15, 2005 each spin-off company withdrew their
respective July 8, 2005 Form 10SBG12 filings.  On August 15, 2005 Barney A.
Richmond filed a reply with the SEC regarding their July 18, 2005
correspondence.  A copy of Mr. Richmond's legal analysis is enclosed as
Exhibit No. 99.5.

On May 3, 2006 the United States Trustee filed a Motion To Dismiss Case or
Convert Case to a Chapter 7.  On May 5, 2005 the United States Trustee filed
a Notice of Hearing set for June 19, 2005.  On June 13, 2006 a letter was
written to the United States Trustee's Office from Michael Yetnikoff, Esq.
of Schiff-Hardin L.P.  The purpose of Mr. Yetnikoff's correspondence was to
request a thirty (30) day extension to this June 19, 2006 hearing to allow

                                      18
CORE MEDICAL GROUP, INC.
(F/K/A SWAP AND SHOP.NET CORP.)
A DEVELOPMENT STAGE ENTERPRISE

the SEC the time to review eCom's proposed Reorganization Plan and Disclosure
Statement.  Mr. Yetnikoff's firm represents petitioning creditors and Plan
Proponent, American Capital Holdings, Inc.  During the period from July thru
August, 2006, the Debtor's attorney of Kluger, Peretz, Kaplin & Berlin and Mr.
Yetnikoff of Schiff-Hardin, LP were in frequent contact with the SEC offices in
Atlanta, Georgia regarding eCom's Joint Plan of Reorganization and Disclosure
Statement.  On July 10, 2006, the Company's attorneys received written notice
from the SEC to leave the treatment of the eCom spinoff companies as is.  On
August 25, 2006 the Joint Plan of Reorganization and Disclosure Statement was
filed by the Debtor, eCom and Petitioning Creditor American Capital Holdings,
Inc.  On September 7, 2006 the SEC notified the eCom's and American Capital
Holdings, Inc's attorneys there were no unsatisfied comments regarding the Plan
and Disclosure Statement.

On December 28, 2006, an Order by the Honorable Judge Steven H. Friedman (I)
Approving Disclosure Statement; (II) Setting Hearing On Confirmation Of Plan;
(III) Setting Hearing on Fee Applications; (IV) Setting Various Deadlines; And
(V) Describing Plan Proponents Obligations.  On January 3, 2007 an amended
Joint Plan of Reorganization and Disclosure Statement was filed by the Debtor,
eCom and  Petitioning Creditor American Capital Holdings, Inc., which was also
reviewed by the SEC.  A copy of the Amended Joint Plan of Reorganization and
Disclosure Statement can be viewed on the eCom November 30, 2006 Form 10QSB
filed on January 16, 2007, SEC accession number 0001000459-07-000001 Exhibits
99.1 and 99.2.   All ballots and/or any objections regarding the Joint Plan of
Reorganization and Disclosure were due to be filed with the Bankruptcy Court by
March 2, 2007. A Confirmation Hearing And Hearing On Fee Applications has been
scheduled for March 12, 2007 at 1:30 p.m. at the United States Bankruptcy
Court, Southern District of Florida, 1515 North Flagler Drive, Room 801,
Courtroom B, West Palm Beach, Florida 33401.

A transcript of the March 12, 2007 hearing is attached as Exhibit 99.6.  As
soon as final orders are given by the bankruptcy court, they will posted on the
eCom website at www.ecomecom.net.

In an abundance of caution to avoid any bankruptcy solicitation rules and to
allow time to procure clarification/court approvals on eCom's Joint Plan of
Reorganization & Disclosure Statement, the Company (list each) withheld filing
its 10QSB filings for the quarterly periods of August 31, 2006 and November 30,
2006 until after the March 2, 2007 Deadline For Filing Ballots Accepting Or
Rejecting Plan. Additionally, as a result of the aforementioned bankruptcy
proceedings the Company has purposely postponed acquisition and funding
commitment discussions until after the March 12, 2007 hearing is completed.

The Company has had no recent revenues or earnings from operations. The Company
will sustain operating expenses without corresponding revenues. This will
result in the Company incurring net operating losses until the Company can
realize profits from the business ventures it intends to acquire.

The success of the Company's proposed plan of operation will depend primarily
on the success of the Company's business operations and the realization of the
business' perceived potential. The funding of this proposed plan will require
significant capital. There can be no assurance that the Company will be
                                      19
CORE MEDICAL GROUP, INC.
(F/K/A SWAP AND SHOP.NET CORP.)
A DEVELOPMENT STAGE ENTERPRISE

successful or profitable if the Company is unable to raise the funds to provide
this capital, or to otherwise locate the required capital for the operations of
the business.

If, for any reason, the Company does not meet the qualifications for listing on
a major stock exchange, the Company's securities may be traded in the over-the-
counter ("OTC") market. The OTC market differs from national and regional stock
exchanges in that it (1) is not sited in a single location but operates through
communication of bids, offers and confirmations between broker-dealers and
(2)securities admitted to quotation are offered by one or more broker-dealers
rather than the "specialist" common to stock exchanges.


RESULTS OF OPERATIONS

Comparison of the six months ended November 30, 2006
  with the six months ended November 30, 2005
-------------------------------------------------------------------

Revenue for the six month periods ended November 30, 2006 and November 30, 2005
was $0.

Cost of sales, which includes depreciation expense, was $0 for both six month
periods.  Operating expenses for the six months ended November 30, 2006 totaled
$(57,397) compared to $(57,710) for the six months ended November 30, 2005.
These charges consisted of general and administrative expenses which included
consulting, professional fees and travel costs and other costs associated with
administrative requirements, including SEC filings.

As a result of the incurrence of the administrative expenses without the
realization of revenues, the net loss for the six months ended November 30,
2006 was also $(57,397) versus a net loss of $(57,710) recorded in the six
months ended November 30, 2005.

Comparison of the three months ended November 30, 2006
  with the three months ended November 30, 2005
-------------------------------------------------------------------
Revenue for the three month periods ended November 30, 2006 and November 30,
2005 was $0.

Cost of sales, which includes depreciation expense, was $0 for both three month
periods.

Operating expenses for the three months ended November 30, 2006 totaled
$(17,785) compared to $(11,117) for the three months ended November 30, 2005.
These charges consisted of general and administrative expenses with the
increase related to higher consulting fees.

As a result of the incurrence of the administrative expenses without the
realization of revenues, the net loss for the three months ended November 30,
2006 was also $(17,785) versus a net loss of $(11,117) recorded in the three
months ended November 30, 2005.
                                     20
CORE MEDICAL GROUP, INC.
(f/k/a Swap and Shop.net Corp.)
A Development Stage Company

Liquidity and Capital Resources
---------------------------------------

Currently there is no trading market for the Company's common stock, and there
can be no assurance that any trading market will ever develop or, if such a
market does develop, that it will continue.  As noted above, upon effectiveness
of a Registration Statement, the Company intends to apply to have its common
stock listed for trading on the American Stock Exchange. If, for any reason,
the Company does not meet the qualifications for listing on a major stock
exchange, the Company's securities may be traded in the over-the-counter
("OTC") market.

The Company continues to be reliant on the private sale of its restricted
common stock plus loans from stockholders and other related parties in order to
fund its operations.


ITEM 3. CONTROLS AND PROCEDURES

EVALUATION OF THE COMPANY'S DISCLOSURE CONTROLS AND INTERNAL CONTROLS:

Within the 90 days prior to the date of this Quarterly Report on Form 10-QSB,
the Company evaluated the effectiveness of the design and operation of its
'disclosure controls and procedures' ("Disclosure Controls"). This 'evaluation'
("Controls Evaluation") was done under the supervision and with the
participation of management, including the Chief Executive Officer/Chairman
("CEO") and Chief Financial Officer ("CFO"). As a result of this review, the
Company adopted guidelines concerning disclosure controls and the establishment
of a disclosure control committee made up of senior management.

LIMITATIONS ON THE EFFECTIVENESS OF CONTROLS:

The Company's management, including the CEO/CHAIRMAN and CFO, does not expect
that its Disclosure Controls or its 'internal controls and procedures for
financial reporting' ("Internal Controls") will prevent all error and all
fraud.
Control system, no matter how well conceived and managed, can provide only
reasonable assurance that the objectives of the control system are met. The
design of a control system must reflect the fact that there are resource
constraints, and the benefits of controls must be considered relative to their
costs. Because of the inherent limitations in all control systems, no
evaluation of controls can provide absolute assurance that all control issues
and instances of fraud, if any, within the Company have been detected. These
inherent limitations include the realities that judgments in decision-making
can be faulty, and that breakdowns can occur because of simple error or
mistake.

Additionally, controls can be circumvented by the individual acts of some
persons, by collusion of two or more people, or by management override of the
control. The design of any system of controls also is based in part upon
certain assumptions about the likelihood of future events, and there can be no

                                     21
CORE MEDICAL GROUP, INC.
(f/k/a Swap and Shop.net Corp.)
A Development Stage Company

assurance that any design will succeed in achieving its stated goals under all
potential future conditions; over time, control may become inadequate because
of changes in conditions, or the degree of compliance with the policies or
procedures may deteriorate. Because of the inherent limitations in a cost-
effective control system, misstatements due to error or fraud may occur and not
be detected.

CONCLUSIONS:

Based upon the Controls Evaluation, the CEO/Chairman and CFO have concluded
that, subject to the limitations noted above, the Disclosure Controls are
effective to timely alert management to material information relating to the
Company during the period when its periodic reports are being prepared.

In accordance with SEC requirements, the CEO/Chairman and CFO note that, since
the date of the Controls Evaluation to the date of this Quarterly Report, there
have been no significant changes in Internal Controls or in other factors that
could significantly affect Internal Controls, including any corrective actions
with regard to significant deficiencies and material weaknesses.


PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

        The Company is not a party to any legal proceedings.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
        None

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.
        None

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
        None

ITEM 5. SUBSEQUENT EVENTS.
        None

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K.

(a)    Exhibits:

EXHIBIT
 NUMBER     DESCRIPTION
--------    -------------------
  31.1      Certification required under Section 302 of the Sarbanes-Oxley Act
             of 2002 by the CEO

  31.2      Certification required under Section 302 of the Sarbanes-Oxley Act
             of 2002 by the CFO

                                      22
CORE MEDICAL GROUP, INC.
(F/K/A SWAP AND SHOP.NET CORP.)
A DEVELOPMENT STAGE ENTERPRISE

  32        Section 1350 Certification

  99.1      June 6, 2005 Court Orders issued by Judge Friedman approving the
             employment of Kluger, Peretz, Kaplan & Berlin, P.L as eCom's
             bankruptcy legal counsel and the approval of Barney A. Richmond
             as CEO of eCom.

  99.2      June 14, 2005 Interim Order for Post Petition $100,000 eCom Debtor-
             in-Possession financing provided by American Capital Holdings.

  99.3      July 18, 2005 letter from the Securities and Exchange Commission
             asking Swap and Shop.net to provide legal analysis for their
             "spin-off" share issuance.

  99.4      July 20, 2005, Motion for permission to perfect notice to
             all interested parties via the eCom website, and the July 25, 2005
             Court Order this Motion To Limit Notice and the use of electronic
             service to notice shareholders

  99.5      August 15, 2005 legal analysis from Barney A. Richmond filed in
             response to the SEC July 18, 2005 letter.

  99.6      Transcript of March 12, 2007 Confirmation Hearing of debtor eCom
             eCom.com, Inc.

 (b)  Reports on Form 8-K:

                             None




                                SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunder duly authorized.

March 23, 2007

By: /s/ Barney A. Richmond

Barney A. Richmond,
Chief Executive Officer

March 23, 2007

By: /s/ Richard C. Turner

Richard C. Turner,
Chief Financial Officer

                                      23
SIGNATURES AND CERTIFICATIONS
EXHIBIT 31.1
CERTIFICATION REQUIRED UNDER SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Barney A. Richmond, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Core Medical Group,
Inc. (f/k/a SWAP AND SHOP.NET CORP.).

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the registrant
as of, and for, the periods presented in this quarterly report;

4. The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:
a) designed such disclosure controls and procedures to ensure that material
   information relating to the registrant is made known to us by others within
   the company, particularly during the period in which this report is
   prepared;
b) evaluated the effectiveness of the registrant's disclosure controls and
   procedures as of a date within 90 days prior to the filing date of this
   report (the "Evaluation Date"); and
c) presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures based on our evaluation as of the Evaluation
Date;

5. The registrant's other certifying officer and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent
function):
a) all significant deficiencies in the design or operation of internal controls
   which could adversely affect the registrant's ability to record, process,
   summarize and report financial data and have identified for the registrant's
   auditors any material weaknesses in internal controls; and
b) any fraud, whether or not material, that involves management or other
   employees who have a significant role in the registrant's internal controls.

6. The registrant's other certifying officer and I have indicated in this
report whether or not there were significant changes in internal controls or in
other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions
with regard to significant deficiencies and material weaknesses.

Date: March 23, 2007
/s/ Barney A. Richmond

Barney A. Richmond
President

                                      24
EXHIBIT 31.2
CERTIFICATION REQUIRED UNDER SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Richard C. Turner, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Core Medical Group,
Inc. (f/k/a SWAP AND SHOP.NET CORP.).

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the registrant
as of, and for, the periods presented in this quarterly report;

4. The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:
a) designed such disclosure controls and procedures to ensure that material
   information relating to the registrant is made known to us by others within
   the company, particularly during the period in which this report is
   prepared;
b) evaluated the effectiveness of the registrant's disclosure controls and
   procedures as of a date within 90 days prior to the filing date of this
   report (the "Evaluation Date"); and
c) presented in this report our conclusions about the effectiveness of the
   disclosure controls and procedures based on our evaluation as of the
   Evaluation Date;

5. The registrant's other certifying officer and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent
function):
a) all significant deficiencies in the design or operation of internal controls
   which could adversely affect the registrant's ability to record, process,
   summarize and report financial data and have identified for the registrant's
   auditors any material weaknesses in internal controls; and
b) any fraud, whether or not material, that involves management or other
   employees who have a significant role in the registrant's internal controls.

6. The registrant's other certifying officer and I have indicated in this
report whether or not there were significant changes in internal controls or in
other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.

Date: March 23, 2007

/s/ Richard C. Turner

Richard C. Turner
Chief Financial Officer

                                      25
CORE MEDICAL GROUP, INC.
(f/k/a Swap and Shop.net Corp.)
A Development Stage Company

EXHIBIT 32

CERTIFICATIONS OF CEO AND CFO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18
U.S.C. SECTION 1350)

In connection with the Registration Statement of Core Medical Group, Inc.
(f/k/a SWAP AND SHOP.NET CORP.), a Florida corporation (the "Company"), on Form
10-QSB for the period ended November 30, 2006 as filed with the Securities and
Exchange Commission (the "Report"), Barney A. Richmond, President of the
Company, and Richard C. Turner, Chief Financial Officer of the Company,
respectively, do each hereby certify, pursuant to Section 906 of the Sarbanes-
Oxley Act of 2002 (18 U.S.C 1350, that to his knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d)of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

/s/ Barney A. Richmond

Barney A. Richmond
President
Date: March 23, 2007


/s/ Richard C. Turner

Richard C. Turner
Chief Financial Officer
Date: March 23, 2007


[A signed original of this written statement required by Section 906 has been
provided to Core Medical Group, Inc. (f/k/a SWAP AND SHOP.NET CORP.) and will
be retained by Core Medical Group, Inc. and furnished to the Securities and
Exchange Commission or its staff upon request.]

The Securities and Exchange Commission has not approved or disapproved of this
Form 10-QSB nor has it passed upon its accuracy or adequacy.









                                       26